Skinvisible Web Sign Up for Updates         T 702.433.7154   |   F 702.433.7192
Skinvisible - Polymer Delivery System

The Ultimate Polymer Delivery System.

Investor Overview

NEW - - - SKVI Now Trading Exclusively on OTCQB

Beginning February 22, 2011 Skinvisible (SKVI) will be quoted exclusively on the new OTCQB www.otcmarkets.com with an icon reading, "OTCQB -- U.S. Registered."

This new designation is used for OTC-traded companies that are U.S. registered and reporting. The OTCQB will help investors easily identify SEC reporting companies such as Skinvisible that are current with their disclosure obligations. As of February 18, 2011, market makers that previously traded Skinvisible on the OTCBB began exclusively trading Skinvisible on the new OTCQB. We do not believe it necessary at this time to reapply for quotation on the OTCBB because of the new trend in trading on the OTCQB.

To get a SKVI quote today, click here:
http://www.otcmarkets.com/stock/SKVI/quote

IMPORTANT: The OTCQB inter-dealer quotation system is interlinked with most financial websites but we encourage you to look at other sites if you do not see a current quote. All financial websites should be up-to-date in the near future.

Shareholder's Information:

Shares Outstanding Are: 110,729,629
Authorized: 200,000,000
Public Float: 55%
Insider Ownership: 45%
Fiscal Year End: December 31


March 25, 2014
Skinvisible's Sunscreen Meets New FDA Guidelines for Broad Spectrum and 80 Minute Water-Resistant Claims - Plus Invisicare Patent Supports Eight Hours of Sunscreen Stabilization

November 5, 2013
Skinvisible Adds Innovative Sunless Tanning Products Available for Exclusive Licensing - Invisicare® Suppresses Odor Associated with Sunless Formulations

June 26, 2013
Skinvisible Adds Additional Patent Protection to Its Topical Drug Delivery Technology - Invisicare® Now Protected in the USA by Five Patents

December 4, 2012
Skinvisible Granted US Patent for Topical Drug Delivery Technology - Invisicare® Patent Protection Extends to Year 2029



CLICK HERE TO READ ALL NEWS RELEASES

In the News:


Skinvisible featured in Drug Development & Delivery journal

Stock Information:


  SEC Filings
  SKVI quote
  Press Releases


Skinvisible Shareholder Update: 2013 in Review




Sign up for Skinvisible Inc. Updates: Click here to join our mailing list.
Home    |     About us    |    Technology    |    Products    |    Investors    |    Contact Us    |    Disclaimer & Privacy    |     Sign Up for Updates
© 2008 Skinvisible Pharmaceuticals, Inc.     Note: This website is not intended for Canadian residents.